A woman sues gynecologist for alleged lack of informed consent.
A Virginia woman saw a new gynecologist for an annual exam in 2000. She was 43-years-old and had a history of multiple pelvic surgeries, including left ovary removal, hysterectomy, right ovary removal, and lysis of adhesions. She also had two vaginal deliveries in the early 1980s. At this visit, she complained of abdominal/pelvic pain and pressure and urinary incontinence. She had a history of constipation, but did not report that to the doctor. On examination and the physician noted a thin sphincter, a cystocele, and a urethrocele. The patient continued to be seen by this doctor over the next year with the same complaints. Surgery was scheduled for 2001 for lysis of adhesions, tension-free vaginal tape with cystoscopy, and posterior repair, which included a rectal plication/sphincteroplasty. At the preoperative visit, the patient signed a consent form for all three procedures, but later claimed that she thought the only procedure to be performed was a "bladder tuck." Three weeks after the procedure, the patient returned complaining of fecal incontinence. She was referred to a colon and rectal surgeon who performed an ultrasound which showed a defect on the anterior side of the sphincter. He performed an overlapping sphincteroplasty, but the patient continued to complain of fecal incontinence. She underwent a colostomy 11 months after the original procedure. She was treated for her colitis, and the colostomy was taken down after 9 months. While she has better control, she continues to complain of fecal incontinence.
The woman sued the gynecologist and alleged lack of informed consent for the rectocele repair and claimed negligence in performing the procedures. She also claimed that the rectocele repair was unnecessary.
The physician argued that the surgery was needed and the patient was fully informed of the risks of the surgery. She also claimed the patient's fecal incontinence was due to several factors and was likely precipitated by changes in her bowel motility and consistency, not from the operation. A defense verdict was returned.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More